Your subscription includes the medication, if it's deemed appropriate by a healthcare provider, a free online assessment and access to medical providers to ensure the treatment is working
Let it absorb into the skin
Ethics declarations Conflict of interest SC received lecture or consultancy fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk
In general, the longer-acting GLP-1 agonists which are injected weekly, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are associated with greater weight loss than the shorter-acting GLP-1 agonists such as liraglutide (Saxenda)
To help prevent muscle loss, experts recommend strength-training exercises, adequate protein intake, and proper hydration throughout treatment
Elliott, A